Additionally, molecular docking studies have demonstrated that Cordycepin can effectively bind to P53 and P21 proteins, supporting its potential mechanism of action in treating PAH (Fig. 11)37. This evidence concerns the gene CDKN1A and pulmonary arterial hypertension.